Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Long-Term Debt Repayments (2016 - 2025)

Historic Long-Term Debt Repayments for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $1.6 million.

  • Haemonetics' Long-Term Debt Repayments changed N/A to $1.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $4.7 million, marking a year-over-year decrease of 9536.99%. This contributed to the annual value of $50.0 million for FY2025, which is 1666.67% down from last year.
  • Latest data reveals that Haemonetics reported Long-Term Debt Repayments of $1.6 million as of Q4 2025.
  • In the past 5 years, Haemonetics' Long-Term Debt Repayments ranged from a high of $51.2 million in Q1 2024 and a low of $1.6 million during Q3 2025
  • For the 5-year period, Haemonetics' Long-Term Debt Repayments averaged around $11.9 million, with its median value being $4.4 million (2021).
  • Per our database at Business Quant, Haemonetics' Long-Term Debt Repayments skyrocketed by 275714.29% in 2024 and then tumbled by 9687.4% in 2025.
  • Quarter analysis of 5 years shows Haemonetics' Long-Term Debt Repayments stood at $4.4 million in 2021, then soared by 902.86% to $43.9 million in 2022, then plummeted by 92.02% to $3.5 million in 2023, then surged by 1328.57% to $50.0 million in 2024, then tumbled by 96.87% to $1.6 million in 2025.
  • Its Long-Term Debt Repayments was $1.6 million in Q4 2025, compared to $1.6 million in Q3 2025 and $1.6 million in Q2 2025.